January 19, 2010Perseid Achieves Preclinical Milestone under Collaboration with Astellas for CTLA-4 Program
REDWOOD CITY, Calif., January 19, 2010 ─ Maxygen,...
More >> July 14, 2009Maxygen Announces Positive Results of MAXY-G34 Phase IIa Study in Breast Cancer Patients
-MAXY-G34 was Effective in Reducing...
More >> June 30, 2009Maxygen Announces Joint Venture with Astellas to Develop Protein Pharmaceuticals
-Maxygen to Contribute R&D Operations and Assets to Newly-Fo...
More >> October 22, 2008Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy
-Phase III Manufacturing for MAXY-G34 Delayed until Partner is ...
More >> September 18, 2008Maxygen and Astellas Announce Global Agreement to Develop New Therapies for Autoimmune Diseases and Transplantation
-Astellas to Receive Rights to Commercialize MAXY-4 CTLA4-Ig Can...
More >> July 2, 2008Bayer HealthCare and Maxygen Announce Hematology Agreement
-Portfolio of hemophilia drug candidates in...
More >> June 11, 2008Maxygen Receives Approval for Clinical Trial of Factor VIIa in the United Kingdom
More >> January 7, 2008Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
Redwood CityMore >> November 26, 2007Maxygen Updates Status of MAXY-alpha Program
REDWOOD CITY, Calif., November 26...
More >> September 21, 2007Maxygen Announces Hold on MAXY-alpha Development Program
More >> July 2, 2007Maxygen Initiates Phase IIa Clinical Trial of MAXY-G34 in Breast Cancer Patients
More >> April 10, 2007Maxygen to Present Review of G-CSF Clinical Program Live at NASDAQ MarketSite® Tuesday, April 17, 8:00 a.m. EST
Redwood City, Calif., April 10, 2007 – Maxygen, Inc. (Nasd...
More >> March 13, 2007Maxygen Announces End of Co-Development Agreement
Redwood City, Calif., March 13, 2007 - Maxygen, Inc...
More >> November 7, 2006Maxygen's Next-Generation Interferon Alpha Enters Phase Ia Clinical Trial
Redwood City, Calif., November 7, 2006 – Maxygen, Inc. (Nasdaq: MAXY...
More >> September 5, 2006Maxygen Initiates Phase I Clinical Trial for Maxy-G34
Redwood City, Calif., September 5, 2006 – Maxygen, Inc. (Nasdaq: MAX...
More >> May 9, 2006Maxygen Achieves Milestone in Alliance with Roche for Factor VIIa Therapeutics
Redwood City, Calif., May 9, 2006—Maxygen, Inc. (Nasdaq: MAXY) today...
More >> December 15, 2005Roche and Maxygen to Co-Develop Recombinant Factor VIIa Therapeutics for Acute Bleeding
NUTLEY, NJ and Redwood City, Calif., December 15, 2005 â...
More >> December 14, 2005Maxygen Announces Achievement of Milestone in Roche Alliance
Redwood City, Calif., December 13, 2005 ? Maxygen, Inc. (Nasdaq: MAXY)...
More >> March 30, 2005Maxygen Announces Achievement of Milestone in Alliance with Roche
Redwood City, Calif., March 30, 2005 ? Maxygen, Inc. (Nasdaq: MAXY) an...
More >> December 3, 2004Maxygen announces new development program and product development prioritization
Redwood City, Calif., December 3, 2004 ? Maxygen, Inc. (Nasdaq: MAXY) ...
More >> September 9, 2004Maxygen and Rentschler Sign Agreement to Manufacture Novel G-CSF
Redwood City, Calif., Laupheim, Germany, September 9, 2004 -- Maxygen,...
More >> July 27, 2004Maxygen Reports Second Quarter 2004 Financial Results
Redwood City, Calif., July 27, 2004 – Maxygen, Inc. (Nasdaq: MAXY) tod...
More >> June 8, 2004Maxygen and Biovitrum Sign Agreement to Manufacture Optimized Beta Interferon for Phase I and II Clinical Trials
Redwood City, Calif., Stockholm, Sweden June 8, 2004 Maxygen, Inc....
More >> May 22, 2003Roche and Maxygen Establish Broad Alliance To Develop and Commercialize Next-Generation Interferon Alpha and Beta Products
Basel, Switzerland and Redwood City, Calif., May 22, 2003 – Roche and ...
More >> October 7, 2002Intermune and Maxygen Announce Progress in Alliance to Develop Once-Weekly Actimmune
InterMune, Inc., (Nasdaq: ITMN) and Maxygen Holdings Ltd., a wholly-ow...
More >> July 24, 2002Maxygen Announces Appointment of Paul Spence, D.Phil.,to Senior Vice President of Research and Development, Human Therapeutics
Redwood City, Calif., July 24, 2002 – Maxygen, Inc. (Nasdaq: MAXY) ann...
More >> February 21, 2002Maxygen Announces Advancement of Improved Interferon Beta for Multiple Sclerosis
Redwood City, Calif., February 21, 2002 – Maxygen, Inc. (Nasdaq: MAXY)...
More >> January 8, 2002Celltech and Maxygen Enter Into Antibody Collaboration
Redwood City, CA and Slough, England– January 8, 2002 - Celltech Group...
More >> October 9, 2001Maxygen Announces Advancement of Human Therapeutics Candidates
Redwood City, Calif., October 9, 2001 – Maxygen, Inc. (Nasdaq: MAXY) a...
More >> September 5, 2001InterMune and Maxygen Form Collaboration to Develop Next-Generation Interferon Gamma Products
Redwood City and Brisbane, Calif., September 5, 2001 – Maxygen Holding...
More >> September 19, 2000Maxygen and H. Lundbeck A/S Enter into Research and Development Agreement
Redwood City, Calif., September 19, 2000 - Maxygen ApS, a wholly owned...
More >> September 15, 2000Maxygen and Shearwater Enter Into Strategic Protein Pharmaceutical Alliance
Redwood City, Calif., and Huntsville, Ala., September 15, 2000 – Maxyg...
More >> August 10, 2000Maxygen Completes Acquisition of ProFound Pharma A/S
Redwood City, Calif., August 10, 2000 – Maxygen (MAXY – Nasdaq) today ...
More >> April 12, 2000Maxygen to Acquire ProFound Pharma A/S to Expand its Position in Protein Pharmaceuticals
Redwood City, Calif., April 27, 2000 - Maxygen, Inc. (Nasdaq: MAXY) to...
More >> February 28, 2000Maxygen Announces Cooperative Research and Development Agreement with The National Cancer Institute for Novel Protein Pharmaceuticals
Redwood City, Calif., February 28, 2000 – Maxygen (MAXY – NASDAQ) anno...
More >>
Return to Protein Therapeutics
|
